Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Using Ketamine to Mitigate Persistent Cognitive Deficits After General Anesthesia

FY 2019-20

Summary
"The number of surgeries performed each year in the world rose from 235 million in 2004 to over 312 million in 2012. Unfortunately, a significant proportion of surgical patients experience deficits in learning and memory that persist for months after the surgery. These cognitive deficits are associated with poor long-term outcomes. Currently, there are no effective treatments for this type of cognitive dysfunction. General anesthetics are a major cause of post-surgical cognitive dysfunction. Most general anesthetic drugs work by briefly enhancing an inhibitory receptor function in the brain, resulting in memory loss and insensitivity to pain for the duration of the surgery. Although this receptor-enhancing effect is supposed to be temporary, in reality there is a sustained increase in the number of the same inhibitory receptor that persists for weeks after anesthetic removal. It is likely that persistent activation of this inhibitory receptor contributes to cognitive dysfunction after surgery, since blockade of the receptor alleviated anesthesia-induced memory deficits in mice. Unfortunately, drugs that target the receptor are not yet clinically approved, due to either lack of efficacy or unwanted side effects in humans. There is, however, a new drug candidate for treating post-surgical cognitive deficits: ketamine. Our preliminary data shows that ketamine can effectively suppress the activity of the inhibitory receptor responsible for cognitive dysfunction after surgery. My project aims to directly test whether ketamine can alleviate memory deficits by reducing the number of the receptor in mice after general anesthesia. Ultimately, we hope to identify a novel, cost-effective approach to prevent cognitive dysfunction in patients undergoing anesthesia and surgery. "
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
428933
Name
Liu Daheng
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Using Ketamine to Mitigate Persistent Cognitive Deficits After General Anesthesia
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Behavior; Cell-Surface Biotinylation; Etomidate; Gabaa Receptor; General Anesthesia; Ketamine; Post-Operative Cognitive Dysfunction; Sevoflurane; Western Blotting
Abstract
"The number of surgeries performed each year in the world rose from 235 million in 2004 to over 312 million in 2012. Unfortunately, a significant proportion of surgical patients experience deficits in learning and memory that persist for months after the surgery. These cognitive deficits are associated with poor long-term outcomes. Currently, there are no effective treatments for this type of cognitive dysfunction. General anesthetics are a major cause of post-surgical cognitive dysfunction. Most general anesthetic drugs work by briefly enhancing an inhibitory receptor function in the brain, resulting in memory loss and insensitivity to pain for the duration of the surgery. Although this receptor-enhancing effect is supposed to be temporary, in reality there is a sustained increase in the number of the same inhibitory receptor that persists for weeks after anesthetic removal. It is likely that persistent activation of this inhibitory receptor contributes to cognitive dysfunction after surgery, since blockade of the receptor alleviated anesthesia-induced memory deficits in mice. Unfortunately, drugs that target the receptor are not yet clinically approved, due to either lack of efficacy or unwanted side effects in humans. There is, however, a new drug candidate for treating post-surgical cognitive deficits: ketamine. Our preliminary data shows that ketamine can effectively suppress the activity of the inhibitory receptor responsible for cognitive dysfunction after surgery. My project aims to directly test whether ketamine can alleviate memory deficits by reducing the number of the receptor in mice after general anesthesia. Ultimately, we hope to identify a novel, cost-effective approach to prevent cognitive dysfunction in patients undergoing anesthesia and surgery. "
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Liu, Daheng
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~